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MSH2 is a key DNAmismatch repair protein, which plays an
important role in genomic stability. In addition to its DNA
repair function, MSH2 serves as a sensor for DNA base analogs-
provoked DNA replication errors and binds to various DNA
damage-induced adducts to trigger cell cycle arrest or apoptosis.
Loss or depletion of MSH2 from cells renders resistance to cer-
tainDNA-damaging agents. Therefore, the level ofMSH2deter-
mines DNA damage response. Previous studies showed that the
level of MSH2 protein is modulated by the ubiquitin-protea-
some pathway, and histone deacetylase 6 (HDAC6) serves as an
ubiquitin E3 ligase. However, the deubiquitinating enzymes,
which regulate MSH2 remain unknown. Here we report that
ubiquitin-specific peptidase 10 (USP10) interacts with and sta-
bilizesMSH2.USP10deubiquitinatesMSH2 in vitro and in vivo.
Moreover, the protein level of MSH2 is positively correlated
with the USP10 protein level in a panel of lung cancer cell lines.
Knockdown of USP10 in lung cancer cells exhibits increased
cell survival and decreased apoptosis upon the treatment of
DNA-methylating agent N-methyl-N-nitro-N-nitrosoguani-
dine (MNNG) and antimetabolite 6-thioguanine (6-TG). The
above phenotypes can be rescued by ectopic expression of
MSH2. In addition, knockdown of MSH2 decreases the cellular
mismatch repair activity. Overall, our results suggest a novel
USP10-MSH2 pathway regulating DNA damage response and
DNAmismatch repair.
Mismatch repair (MMR)3 is a mutation avoidance mecha-
nism that corrects DNA replication errors, and controls homo-
logous recombination (HR) by aborting strand exchange
between divergent DNA sequences (1). The MMR activity
begins with mismatch recognition, which is carried out either
by MutS (MSH2-MSH6) or by MutS (MSH2-MSH3).
MutS recognizes DNA single base pair mismatches and small
deletions/insertions, whereas MutS recognizes large dele-
tions/insertions (2, 3). MutS or MutS then recruits MutL
(MLH1-PMS2), proliferation cellular nuclear antigen (PCNA),
and replication protein A (RPA) to form a complex leading to
the recruitment of exonuclease 1 (EXO1) to the strand break.
EXO1 then cut the nascent DNA from the nick forward and
beyond the mismatch to generate a single strand gap, which is
filled by polymerases  using the parental DNA strand as a
template. The repair is accomplished by filling the nick using
DNA ligase I. Deletion or mutation of key DNA mismatch
repair proteins, such as MSH2 and MLH1, can cause genomic
instability (4).
n addition to recognizing DNAmismatchesMutS can rec-
ognize certain DNA-damaging agents, such as 6-thioguanine
(6-TG)-, N-methyl-N-nitro-N-nitrosoguanidine (MNNG)-,
and cisplatin-induced DNA adducts to trigger apoptosis (5).
Thus, the level of MutS controls cellular sensitivity to DNA
damage. It has been reported that the level of MSH2 can be
modulated bymultiplemeans. First, when cells are treated with
ultraviolet (UV) or phorbol ester (TPA), the mRNA level of
MSH2 will be increased (6, 7). Second, MSH2 protein is more
stable as a heterodimer withMSH6 than it exists as a monomer
(8). Third, protein kinase C (PKC) phosphorylates MutS and
protects it from proteasome-dependent degradation (9).
Fourth, histone deacetylase 6 (HDAC6) was recently identified
as an E3 ligase of MSH2 to promote its degradation (8). How-
ever, the deubiquitinating enzyme (DUB), which counteracts
HDAC6 to stabilize MSH2, has remained unknown.
Currently about 100DUBs have been identified in the human
genome and are classified into five families based on their
sequence similarity andmechanismof action (10–14). They are
1) the ubiquitin C-terminal hydrolases (UCHs), 2) the ubiqui-
tin-specific proteases/ubiquitin-specific processing proteases
(USPs/UBPs), 3) the ovarian tumor proteases (OTUs), 4) the
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Josephin orMachado-Joseph disease protein domain proteases
(MJDs), and 5) the Jab1/MPN domain-associated metalloiso-
peptidase (JAMM) domain proteins. The first four families are
cysteine peptidases, while the last one comprises of zinc
metalloisopeptidases.
USP10 belongs to the USP family and is identified as a new
regulator of p53 in DNA damage response and tumor develop-
ment (15–17). Yuan et al. found that phosphorylation of USP10
onThr-42 and Ser-337 byATM leads toUSP10 translocation to
the nucleus to stabilize p53 (15). The other USP10-interacting
proteins include Ras GTPase-activating protein-binding pro-
tein 1 (G3BP1), cystic fibrosis transmembrane conductance
regulator (CFTR), and a histone H2A variant, H2A.Z (18–21).
Among these USP10 partners, G3BP1 binding to USP10 may
blockUSP10’s enzyme activity. CFTR andH2A.Z are substrates
of USP10. USP10 deubiquitinates CFTR to regulate CFTR’s
post-endocytic sorting, while USP10 deubiquitinates H2A.Z to
transcriptionally activate androgen receptor (AR)-regulated
PSA and KLK3 genes (21).
Here, we report MSH2 as a new USP10-interacting protein
and a new USP10 substrate. We also reveal a novel USP10-
MSH2 pathway regulating MSH2 homeostasis, DNA damage
response, and DNAMMR.
Experimental Procedures
Cell Culture and Transfection—All cell lines were grown in
Dulbecco’s modified Eagle’s Medium (DMEM) with 10% fetal
bovine serum, penicillin (100 U/ml), and streptomycin (100
g/ml), except H1299, which was grown in RPMI 1640 medium.
Cells were incubated at 37 °C with 5% CO2. The plasmids were
transiently or stably transfected into cells, except MEFs, using
Lipofectamine 2000 (Invitrogen). The plasmids were trans-
fected into MEFs by electroporation with a Nucleofector™
device (Lonza).
Plasmids, Antibodies, and Chemicals—The expression plas-
mids of F-USP10 and His-USP10 were described in Yuan et al.
(15). F-USP10 (C424A) was generated using F-USP10 as a tem-
plate. The F-HA-USP10 plasmid was purchased fromAddgene
(#22543). TheHA-USP10 plasmidwas constructed by inserting
the USP10 full-length cDNA into the pCMV-HA-N vector
(Clontech) between the XhoI and NotI sites. The full-length
USP10 cDNA was the PCR product using F-USP10 as the tem-
plate. Fragments of USP10-(1–600) and USP10-(601–798)
were cloned into a pCMV-3XFlag vector (Sigma) to generate
F-USP10-(1–600) and F-USP10-(601–798), respectively. The
HA-MSH2 construct was described in Zhang et al. (8). MSH2
cDNA was cloned into the pcDNA4v-His vector (Addgene) to
generate His-MSH2. MSH2 full-length and MSH2 fragments
were cloned into the pGEX vector to generate GST-MSH2,
GST-MSH2-(1–378), GST-MSH2-(200–700), and GST-
MSH2-(624–934). Human USP10 shRNAs (RHS4533-NM_
005153) in the pGIPZ lentiviral vector were purchased from
Open Biosystems. The shUSP10–1 (TRCN0000007430) tar-
gets USP10 sequence: GCCTCTCTTTAGTGGCTCTTT; the
shUSP10–2 (TRCN0000007431) targets sequence: CCTATGT
GGAAACTAAGTA.
The anti-USP10 antibody (ab72486) was purchased from
Abcam. The anti-MSH2 antibody was purchased from Calbi-
ochem. The anti-HA antibody was purchased from Covance.
The anti-Flag M2 antibody and agarose beads, the anti--actin
antibody, MG132, cycloheximide, 6-TG, imidazole, urea, gua-
nidine-HCL, ATP, and MTT were purchased from Sigma.
MNNG was purchased from Pfaltz &Bauer, Inc. Ni-NTA resin
was purchased from Clontech. Rabbit reticulocyte lysate was
purchased from Promega. HA-UB was purchased from Boston
Biochem.
MNNG and 6-TG Treatment—MNNG was diluted in water
immediately before use. Cells were treatedwithMNNG in FBS-
free medium. Cells were then washed with medium and incu-
bated in fresh medium at 37 °C for different time periods as
indicated in the figures. 6-TG was first dissolved in DMSO to
make a stock solution and then dissolved in medium directly
before use.
Immunoprecipitation and Immunoblotting—For immuno-
precipitations, cells were lysed in the LS buffer (PBS, pH 7.5,
10% glycerol, 0.1% Nonidet P-40, protease inhibitor mixture).
Lysates were incubated with protein A- or protein G-agarose
for 2 h for pre-clearing prior to incubation with the indicated
primary antibodies for 12 h at 4 °C. Immunocomplexes were
collected, washed four times in TBST buffer (0.1% Tween-20 in
TBS), and resolved by SDS-PAGE. For immunoblotting, sam-
ples were transferred to nitrocellulosemembranes then probed
with the indicated antibodies. Bound antibodies were detected
using a Chemiluminescent Detection Kit (Pierce).
Establishment of USP10-knockdown Stable Clones—For Figs.
2B and 3B, the pGIPZ vector containing shUSP10–2was trans-
fected into A549 and H1299. One day after transfection, cells
were split into 3 dishes. After 24 h, 1 g/ml puromycin was
added into the medium to select positive cells. Ten days later,
stable cell lines were subcloned to 60-mm dishes, 0.5 g/ml
puromycin was added to the medium to maintain the stable
clones in the subsequent culture.
Establishment of the USP10-knockdown A549 Pool—Add-
gene’s protocol was followed to produce lentiviral particles and
infect A549 cells. Briefly, pGIPZ vector containing shUSP10–1
or shUSP10–2 was co-transfected with psPAX2 and pMD2.G
into HEK-293T cells. Lentiviral particles in the HEK-293T cell
medium were harvested 24 and 36 h after transfection. Then,
the lentiviral particle solutionwas added into A549 cells. About
24 h after infection, puromycin was added to themedium at the
concentration of 1 g/ml for A549 cells. After a 2-week selec-
tion, Western blot analyses were used to determine the knock-
down efficiency.
GST Pull-down Assay—GST fusion proteins were purified as
previously described (22). For in vitro binding assays, glutathi-
one Sepharose-bound GST-MSH2 proteins were incubated
with cell lysates. After washing extensively with PBST (0.1%
Tween 20 in PBS), the proteins bound to GST-MSH2 were
resolved by SDS-PAGE and immunoblotted with indicated
antibodies.
In Vitro Ubiquitination and Deubiquitination Assays—The
in vitro ubiquitination assay is described in our previous report
(23). Briefly, glutathione-Sepharose-bound GST-MSH2 was
incubated with 5 mM ATP, 200 M HA-Ub, and rabbit reticu-
locyte lysate (RRL) in ubiquitination buffer (50 mM Tris-HCl,
pH 7.5, 100mMNaCl, 2.5 mMMgCl2, and 1mMDTT) for 2 h at
USP10 DeubiquitinatesMSH2
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37 °C. Beads were washed with PBST 3 times followed by the
deubiquitination buffer (50 mM Tris-HCl, pH 8.0, 50 mMNaCl,
1 mM EDTA, 10 mM DTT, 5% glycerol) once. Ubiquitinated
GST-MSH2 as a substrate was incubated with purified
F-USP10 from 293T cells in deubiquitination buffer at 37 °C for
1 h. The reaction was stopped by SDS-loading buffer followed
by immunoblotting.
In Vivo Ubiquitination Assay—His-MSH2 was co-trans-
fected with empty vector, F-USP10 or F-USP10 (C424A) into
293T cells. Thirty-six hours post-transfection, cells were har-
vested. Cell pellets were lysed in Buffer A (6 M guanidine-HCl,
0.1 M Na2HPO4/NaH2PO4, 0.01 M Tris-HCl, pH 8.0, 10 mM
imidazole, 10 mM -mecaptoethanol) and 30 l of Ni-NTA
agarose beads were added, and themixture was rotated at room
temperature for 12 h. The beads were sequentially washed with
BufferA, Buffer B (8Murea, 0.1MNa2HPO4/NaH2PO4, 0.01M
Tris-HCl, pH 8.0, 10 mM -mercaptoethanol), Buffer C (8 M
urea, 0.1 M Na2HPO4/NaH2PO4, 0.01 M Tris-HCl, pH 6.3, 10
mM -mercaptoethanol), and Buffer C plus 0.1% Tween-20,
then resolved on SDS-PAGE followed by the anti-Ub Western
blotting analysis.
Whole Cell Extract Preparation—Whole cell extracts were
prepared from 6  107 cells as described (24). Cells were first
washed with buffer A (20 mM Hepes pH 7.5, 5 mM KCl, 0.5 mM
MgCl2, 0.1% PMSF, 0.5 mM DTT, 1 g/ml leupeptin, and 0.2 M
sucrose) and lysed in the same buffer without 0.2 M sucrose by
passage through a 27-gauge needle. Proteins were precipitated
by 65% of ammonium sulfate, collected by centrifugation,
resuspended in lysis buffer, followed by dialysis to equilibrium
in a buffer containing 20mMHepes (pH 7.5), 5 mMKCl, 0.1 mM
EDTA, 0.1% PMSF, 0.5 mM DTT, and 1 g/ml leupeptin.
Heteroduplex Preparation and MMR Assay—DNA sub-
strates used in this study are circular heteroduplex DNA con-
taining a unique G-T mismatch and a strand break 3 to the
mismatch (Fig. 6). The substratewas prepared fromM13mp18-
UKY phase series as described previously (25). MMR assays
were performed in 20-l reactions containing 100 ng hetero-
duplex DNA, 75 g of whole cell extracts, 10 mM Tris-HCl (pH
7.5), 5 mM MgCl2, 1.5 mM ATP, 0.1 mM dNTPs, 1 mM glutathi-
one and 110mMKCl at 37 °C for 15min, as described (24) in the
presence or absence of purified human recombinant MutS
(26). Reactions were terminated by addition of Proteinase K.
DNA samples were extracted with phenol and recovered by
ethanol precipitation. Repair products were digested with PstI,
NsiI (repair-scoring enzyme), and BglI, fractionated by poly-
acrylamide gel electrophoresis, and detected by Southern blot
hybridization with a 32P-labeled probe. DNA products were
visualized by phosphorimager.
Results
USP10 Interacts with MSH2—We previously identified
HDAC6 as an ubiquitin E3 ligase ofMSH2 (8). To identify novel
MSH2-interacting proteins associated with the ubiquitin-pro-
teasome pathway, we overexpressed HA-MSH2 in 293T cells
for 48 h followed by treatment with 50 MMG132 for 4 h. The
HA-MSH2 protein was immunoprecipitated (IP-ed) with
anti-HA agarose beads, and the unique bands existing in the
anti-HA, but not in the control anti-IgG, immunoprecipitate
were excised and analyzed by the liquid chromatography-tan-
dem mass spectrometry (LC-MS/MS). The mass spectrometry
analysis identified 14 peptide sequences of USP10, a ubiquitin-
specific peptidase (data not shown), suggesting that USP10
exists in the anti-MSH2 immunoprecipitate. Reciprocally,
endogenous USP10 was IP-ed by anti-USP10 antibodies in
HeLa S3 cells. The immunoprecipitate was resolved by SDS-
PAGE, and the bands were excised and examined by LC-MS/
MS. MSH2 was identified in the USP10 immunoprecipitate
(data not shown), suggesting that USP10 is associated with
MSH2.
We next confirmed the interaction between USP10 and
MSH2 by performing co-IP assays with anti-USP10 antibodies
using 293T and mouse embryonic fibroblasts (MEFs) cell
extracts. As shown in Fig. 1A, MSH2 was only detected in the
anti-USP10 immunoprecipitates (lanes 3 and 6), but not in the
anti-IgG controls (lanes 2 and 5). In a reciprocal fashion, the
anti-MSH2 antibody, but not anti-IgG, specifically IP-ed
USP10 in HeLa and MEFs (Fig. 1B). Therefore, USP10 and
MSH2 indeed interact with each other in vivo.
To determine whether USP10 directly interacts with MSH2
or through other associated proteins, the in vitro GST pull-
down assay was carried out. As shown in Fig. 1D, GST-MSH2,
but not GST, was able to pull down His-USP10 (lanes 1 and 2).
This result strongly indicates a direct interaction between
USP10 and MSH2.
We next attempted to map which region of MSH2 binds to
USP10.MSH2 can be divided into five domains according to its
crystal structure, namely mismatch binding, connector, level,
clamp, and ATPase (Fig. 1C) (27). As shown in Fig. 1D, the N
terminus of MSH2 (1–378), but not the middle region (200–
700) or C terminus of MSH2-(624–934), binds to USP10
directly (lanes 3, 4, and 5). Thus, the major region responsible
for the interaction with USP10 is located in themismatch bind-
ing and connector domains of MSH2.
We then examined which region of USP10 binds to MSH2.
Human USP10 contains an ubiquitin C-terminal hydrolase
domain (412–792) for its deubiquitination activities (Fig. 1E).
The N terminus of USP10 has been reported to interact with
p53 (15) and G3BP (18). By contrast, as shown in Fig. 1F, the C
terminus of USP10 interacts with MSH2 (lane 3).
We also examinedwhether USP10’s enzymatic activity influ-
ences its binding to MSH2. As shown in Fig. 1F, the USP10
catalytically deadmutant (18), USP10 (C424A), interacted with
MSH2 to the same extent as the wild type did (lanes 4 and 5),
suggesting that the interaction between USP10 and MSH2 is
independent of USP10 enzymatic activity.
USP10 Stabilizes MSH2—We previously showed that
HDAC6 serves as an ubiquitin E3 ligase to promote MSH2’s
degradation (8). Here we explored whether USP10 can coun-
teract HDAC6 to stabilize MSH2. As shown in Fig. 2A, in 293T
cells, the level of HA-MSH2 increased significantly by overex-
pressing USP10; in MEFs, the level of endogenous MSH2
increased dramatically by overexpressing of USP10, as well. To
verify whether USP10 regulates the level of MSH2, we knocked
down USP10 by shRNA against USP10 in A549 and H1299
cells. As shown in Fig. 2B, the level of MSH2 was significantly
decreased in the USP10 knockdown A549 and H1299 cells
USP10 DeubiquitinatesMSH2
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compared with that of MSH2 in the control cells. We then
examined whether USP10 influences the stability of MSH2 by
measuring the half-life of MSH2. As shown in Fig. 2, C and D,
MSH2 half-life in the USP10-knockdown A549 cells is around
6 h, while MSH2 half-life in control cells is more than 12 h,
suggesting that USP10 can prolong MSH2’s half-life. We next
used a USP10 inhibitor, known as specific and potent
autophagy inhibitior-1 (Spautin-1) to treat A549 cells. As
shown in Fig. 2E, Spautin-1 was able to decrease the level of
MSH2, but not USP10, in a time-dependent manner, suggest-
ing that suppressing the deubiquitinating enzyme activity of
USP10 reduces the protein level of MSH2.
We next surveyed a panel of lung cancer cell lines to deter-
mine whether there is a positive correlation between USP10
and MSH2 in these cell lines. As shown in Fig. 2, F and G, the
expression ofMSH2 is positively correlated to the expression of
USP10, indicating that USP10 stabilizes MSH2 in lung cancer
cells.
USP10 Deubiquitinates MSH2—We then determined
whether MSH2 is a substrate of USP10. As shown in Fig. 3A,
FIGURE 1. USP10 interacts with MSH2. A and B, endogenous USP10 and MSH2 interact with each other. A, 293T cells and MEFs were lysed and immunopre-
cipitated (IP-ed) with either anti-IgG or anti-USP10 antibodies followed by an anti-MSH2 Western blotting analysis (upper panel). The blot was stripped and
reprobed with anti-USP10 antibodies (lower panel). B, HeLa cells and MEFs were lysed and IP-ed with either anti-IgG or anti-MSH2 antibodies followed by an
anti-USP10 Western blotting analysis (upper panel). The blot was stripped and reprobed with anti-MSH2 antibodies (lower panel). C, diagrams of the domain
structure of MSH2 and the deletion constructs of MSH2.D,USP10 physically interacts with MSH2, and the N terminus of MSH2 binds to USP10. Escherichia coli
lysates harboringHis-USP10were incubatedwithbacterially-purifiedGST,GST-MSH2,GST-MSH2-(1–378), GST-MSH2-(200–700), orGST-MSH2-(624–934). GST
pull-down was performed followed by an anti-His Western blotting analysis (upper panel). Protein expression of GST, GST-MSH2, GST-MSH2-(1–378), GST-
MSH2-(200–700), and GST-MSH2-(624–934) was shown by Coomassie Blue staining (lower panel). E, diagrams of USP10 domain structure and USP10 deletion
constructs. The numbers indicate the amino acids. UCH stands for the ubiquitin C-terminal hydrolase domain. F, C terminus of USP10 binds MSH2. Both wild
type and catalytically-dead mutant of USP10 bind MSH2. Bacterially purified GST-MSH2 was incubated with 293T cell lysates transfected with Flag-empty
vector (F-vector) or indicated USP10 constructs. The GST pull-down analyses were performed followed by an anti-FlagWestern blotting analysis (upper panel).
The input of Flag-USP10 deletion proteins and wild type (WT) and catalytically-deadmutant (C424A) of USP10 proteins was detected by an anti-FlagWestern
blotting analysis (middle panel). The amount of GST-MSH2used for GST pull-down assayswas examinedby an anti-GSTWestern blotting analysis (lower panel).
USP10 DeubiquitinatesMSH2
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overexpression of USP10 reduced the ubiquitination of
F-MSH2 in A549 and H1299 cells. Conversely, knockdown of
USP10 significantly increased the ubiquitination of MSH2 in
A549 and H1299 cell lines (Fig. 3B).
To directly examine the deubiquitination activity of USP10
toward MSH2, we utilized a cell-free system. We prepared
ubiquitinated GST-MSH2 (Ub-GST-MSH2) as described in
“Experimental Procedures” and then performed the deubiquiti-
nation assay. As shown in Fig. 3C, F-USP10 efficiently deubiq-
uitinated MSH2 in vitro (compare lanes 2 and 3).
We then tested whether USP10 is able to deubiquitinate
MSH2 in vivo. As shown in Fig. 3D, USP10WT, but not USP10
(C424A), reduced His-MSH2 ubiquitination. To ensure that
the ubiquitination signal was indeed from His-MSH2 and not
from its associated proteins, His-MSH2 was washed under the
denaturing conditions and the ubiquitination status was exam-
FIGURE 2.USP10 regulates the protein level and half-life of MSH2. A, USP10 up-regulates the protein level of MSH2 in 293T cells and MEFs. 293T cells and
MEFswere transfectedwith indicatedconstructs and theWesternblottinganalyseswereperformedby indicatedantibodies.B, knockdownofUSP10decreases
the protein level of MSH2 in A549 and H1299 cells. A549 and H1299 cells were stably transfected with empty vector or vector containing USP10 shRNA
(shUSP10–2). The cells were lysed, and the anti-MSH2, anti-USP10, and anti--actin Western blotting analyses were performed as indicated. C, knockdown of
USP10 shortensMSH2 half-life in A549 cells. A549 cells transducedwith lentiviruses containing empty vector or USP10 shRNA (shUSP10–2) were treated with
20 g/ml cycloheximide (CHX) with the indicated times followed by Western blotting analyses with indicated antibodies. The MSH2 and USP10 bands were
quantified by densitometry. The level of MSH2 and USP10 at time point 0 was designated as 1. The levels of USP10 and MSH2 at other times were quantified,
relative to the time point zero, and were shown in fold changes below the panels of MSH2 and USP10. D, a graph of the mean band intensities from three
independent experiments as measured by Image-Pro Plus 6.0 shows the approximate half-lives in the presence of CHX. The error bars represent the standard
deviation. E, Spautin-1 decreases the level of MSH2 but not USP10. A549 cells were treated with 10 M Spautin-1 at indicated times. Cells were lysed, and the
anti-MSH2, anti-USP10, andanti--actinWesternblotting analyseswereperformed. TheMSH2andUSP10bandswerequantified as inC. F, expressionofUSP10
and MSH2 in a panel of lung cancer cell lines. The indicated cell lines, H23, H2122, A549, H1975, H292, H441, H157, H1650, and H661, were lysed, and the
anti-USP10, anti-MSH2, and anti--actin Western blotting analyses were performed. G, MSH2 expression is positively correlated with the USP10 expression in
a panel of lung cancer cells. The bands of USP10 and MSH2 in 2Fwere quantified by densitometry as 2C. The correlation analysis was performed by the SPSS
software, and the resultswere shownas a scatter plot indicating the correlationofMSH2andUSP10expression in these cell lines. Pearson correlation (0.85) and
p value (0.004) were indicated.
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ined by the anti-UbWestern blotting analysis. Overall, we dem-
onstrated that MSH2 is a substrate of USP10.
Depletion of USP10 Decreases Cellular Sensitivity to MNNG
and 6-TG and Decreases DNA Mismatch Repair Activities in
A549 Cells—The MSH2-MSH6 heterodimers recognize DNA-
damaging agents, such as 6-TG,MNNG, cisplatin, carboplatin,
doxorubicin, and etoposide, which form DNA adducts that
cannot be removed by MMR (5). It has been well documented
that the levels of MSH2 are inversely correlated with 6-TG or
MNNG resistance (5). Because USP10 is able to up-regulate the
level of MSH2, we set out to test whether USP10 plays a role
in regulating MNNG- or 6-TG-mediated cell killing. We de-
pleted the expression of USP10 using two different shRNAs
(shUSP10–1 and shUSP10–2) in A549 cells and measured the
cytotoxicity of MNNG and 6-TG by MTT assays. As shown in
Fig. 4, A and B, knockdown of USP10 using both shUSP10–1
and shUSP10–2 in A549 cells significantly increased cell sur-
vival compared with the control cells. To determine whether
this increased survival is due to the decrease of apoptosis, we
detected the cleavage of poly ADP-ribose polymerase 1
(PARP-1) by Western blotting analyses. As shown in Fig. 1C,
knockdown of USP10 with either shUSP10–1 or shUSP10–2
decreased the PARP-1 cleavage upon MNNG and 6-TG treat-
ment compared with the control. To ensure that the increased
cell survival is due to the reduction of MSH2, HA-MSH2 was
introduced to the A549 pools transduced by shUSP10–1 or
shUSP10–2 lentiviruses, and the resulting cells displayed
decreased cell survival and increased apoptosis upon 6-TG or
MNNG treatment (Fig. 5). Therefore, our data suggest a
USP10-MSH2 pathway governing cellular sensitivity to 6-TG
and MNNG. In addition, we explored whether depletion of
USP10 affects DNAMMR activities. As shown in Fig. 6, knock-
down of USP10 in A549 cells significantly reduces the MMR
activities, while the addition of the MutS complex partially
FIGURE 3.USP10deubiquitinatesMSH2. A, USP10 deubiquitinatesMSH2 in vivo. A549 andH1299 cells were transfectedwith the indicated plasmids. Twelve
hours prior to harvest, 10 M MG132 was added to the cells. F-MSH2 was IP-ed by anti-Flag antibodies. The immunoprecipitates were then subjected to the
anti-Ub Western blotting analysis (upper panels). The blot was stripped and reprobed with anti-Flag antibodies (middle panels). The expression of HA-USP10
was detected by the anti-HA Western blotting analysis (lower panels). B, knockdown of USP10 increases MSH2 ubiquitination in vivo. USP10 was stably
transfected by vector control or shRNA against USP10 (shUSP10–2) in A549 and H1299. The cells were treated overnight with 25 M MG132 prior to harvest.
MSH2was IP-ed by anti-MSH2 antibodies. The immunoprecipitates were then subjected to an anti-UbWestern blotting analysis (upper panels). Ten percent of
the above IP-ed samples was subjected to the anti-MSH2 Western blotting analysis for determining IP efficiencies (lower panels). C, USP10 deubiquitinates
ubiquitinated MSH2 in vitro. The Ub-GST-MSH2 protein was prepared as described in the “Experimental Procedures.” Ub-GST-MSH2 was incubated in the
absence or presence of F-USP10 protein purified from293T cells in the deubiquitination buffer (50mMTris-HCl, pH 8.0, 50mMNaCl, 1mM EDTA, 10mMDTT, 5%
glycerol) at 37 °C for 1 h. The reaction was resolved on SDS-PAGE followed by an anti-Ub Western analysis (upper panel). The amount of GST-MSH2 was
examined by an anti-GSTWestern blotting analysis (lower panel).D, USP10-WT, but not USP10-(C424A) mutant, deubiquitinates MSH2 in vivo. 293T cells were
transfected with indicated constructs. His-MSH2 was pulled down with Ni-NTA-agarose beads under denaturing conditions followed by anti-Ub Western
blotting analysis (upper panel). The expression of His-MSH2 and USP10-WT and the USP10-CA mutant was examined by anti-His (middle panel) and anti-Flag
(bottom panel) Western blotting analyses.
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restores MMR activity. This result indicates that USP10 regu-
lates the cellular MMR activities via modulating the level of
MSH2.
Discussion
In this study, we have identified a novel MSH2-interacting
protein, USP10, which stabilizes and deubiquitinates MSH2 in
vitro and in vivo. The USP10-MSH2 axis regulates the MSH2
and MutS homeostasis and cellular sensitivity to DNA dam-
age. We previously demonstrated an unexpected E3 ligase
activity of HDAC6, which regulatesMSH2 proteasome-depen-
dent degradation (8). We have now identified a deubiquitinat-
ing enzymeUSP10, which counteracts HDAC6’s activity. How-
ever, how HDAC6 and USP10 work in concert to regulate
MSH2 stability is not clear. Based on our domainmapping data,
HDAC6 and USP10 bind to different domains of MSH2.
HDAC6 binds to MSH2 C-terminal region (8), while USP10
binds to MSH2 N-terminal region. Therefore, HDAC6 and
USP10 may not compete with each other to bind to MSH2.
Unlike one of USP10 substrates, p53, which has a very short
half-life, MSH2 has a much longer half-life. We suspect that
USP10-mediated deubiquitination of MSH2 may partially
account for MSH2 stability. We previously identified four
C-terminal lysines (Lys-845, Lys-847, Lys-871, and Lys-892) in
MSH2, which can be either acetylated or ubiquitinated (8). We
proposed that HDAC6 sequentially deacetylates at these four
sites to dissemble theMSH2-MSH6heterodimers and ubiquiti-
nates the monomer of MSH2. Thus, USP10 may promote deu-
biquitination of the MSH2 monomer to facilitate MSH2 acety-
lation and theMSH2-MSH6dimer formation.We are currently
testing this hypothesis in the laboratory.
We also found thatUSP10 interactswithMSH6 in vivo by the
immunoprecipitation assay (data not shown). However, we
failed to show that USP10 physically interacts withMSH6. So it
is possible that USP10 influences MSH6’s function through a
direct interaction with MSH2.
We previously showed that upon 6-TG and MNNG treat-
ment, the level ofMSH2ubiquitinationwas decreased (data not
shown andRef. 8). Thus, it is likely thatUSP10 ismore activated
under the 6-TG or MNNG treatment and deubiquitinates
MSH2 more efficiently. Yuan et al., reported that under stress
conditions, such as ionizing radiation (IR), USP10 can be phos-
phorylated by ATM and translocate to the nucleus to stabilize
p53 (15).We recently showed that USP10 phosphorylation was
increased upon MNNG treatment. A MAPK/CDKs family
kinase might be responsible for USP10 phosphorylation (data
not shown). Further studies are needed to elucidate how
MNNG-induced USP10 phosphorylation affects its enzymatic
activity to regulate MSH2 stability.
FIGURE 4. Depletion of USP10 in A549 cells confers MNNG and 6-TG resistance. A, knockdown of USP10 increases cell viability to MNNG. A549 cells
transduced with lentiviruses containing empty vectors, shUSP10–1 or shUSP10–2 were treated with MNNG of the indicated concentration for 2 days and 3
days. MTT assays were performed. B, knockdown of USP10 increases cell viability to 6-TG. A549 cells transduced with lentiviruses containing empty vectors,
shUSP10–1or shUSP10–2were treatedwith 6-TG.MTT assayswere performed.C, knockdownofUSP10 reduces apoptosis upon treatment ofMNNGand6-TG.
A549 cells transducedwith lentiviruses containing empty vectors, shUSP10–1 or shUSP10–2were treatedwithMNNG or 6-TG at indicated times and concen-
trations. Cells were lysed, and the anti-PARP1 and anti--actinWestern blotting analyses were performed. For A and B, the error bars stand for a standard error
(S.E.). **, denotes p 0.001 by a two-tailed Student’s t test (n 6).
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To explore whether USP10 andMSH2 can serve as biomark-
ers for the sensitivity of chemotherapeutic drugs in lung cancer
patients, we examined themRNA levels ofUSP10 andMSH2by
qRT-PCR in a cohort of non-small cell lung cancer patients
under clinical trials (28). We found that there was a positive
correlation between USP10 and MSH2.4 Future studies will
determine the protein levels of USP10 and MSH2 in these
patients to examine whether USP10 also stabilizes MSH2 in
lung cancer patients.
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